Pubdate: Tue, 31 May 2005 Source: Wall Street Journal (US) Copyright: 2005 Dow Jones & Company, Inc. Contact: http://www.wsj.com/ Details: http://www.mapinc.org/media/487 Author: Heather Won Tesoriero Bookmark: http://www.mapinc.org/find?232 (Chronic Pain) Bookmark: http://www.mapinc.org/oxycontin.htm (Oxycontin/Oxycodone) PURDUE PHARMA, H.D. SMITH PLAN TEST OF ELECTRONIC TRACKING OF DRUGS Several companies are expected to announce today the first commercial effort to use a radio-frequency identification-tracking system for drugs. Starting in July, Purdue Pharma LP, maker of painkiller OxyContin, and drug wholesaler H.D. Smith will be trying out the "electronic pedigree" tracking system to record the movement of Purdue Pharma's drugs. Two technology companies are working with Purdue Pharma and H.D. Smith on the system, which could serve as a national model because it is the first to comply with pending state legislation. With more than a dozen states pushing for laws that will create a record of the path a drug takes from manufacturer to patient, the drug industry is trying to develop a viable electronic-tracking system. An increase in counterfeit drugs is prompting greater vigilance and control over the nation's drug supply. Regulators have said the current system is easily susceptible to tampering and theft. In many instances, state lawmakers and industry favor tracking systems that use electronic fingerprints. Some wholesalers and pharmacy operators have said an electronic system is too costly. There has been great debate in the industry over who will be responsible for implementing radio-frequency identification-tracking systems or other electronic-tracking technologies. With RFID, tiny tags with radio antennas are placed on products and then read and recorded at each stop along the supply chain. By the time the drugs reach a patient, there is a record of where they have been. The pilot program reflects the work of four companies. According to Aaron Graham, vice-president of corporate security at Purdue Pharma, of Stamford, Conn., the drug maker has spent $2 million on the technology. Now when its products, including the widely abused painkiller OxyContin, are sold to wholesaler H.D. Smith, of Springfield, Ill., both companies will have an electronic record of each drug's path. Technology company SupplyScape Corp., Cambridge, Mass., pioneered the software that produces the electronic pedigree. Unisys Corp., Blue Bell, Pa., is implementing the technology for the drug maker and wholesaler. Florida and Indiana recently passed pedigree laws, which will become effective in July 2006. Though by law, the industry can adopt paper or electronic pedigrees, "the technology is available now," said Brenda Kelly, vice president of marketing for SupplyScape, indicating that this likely will be the choice for a national standard. - --- MAP posted-by: Beth